Updated: January 23, 2026
Jublia Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Learn about Jublia's common and serious side effects, what's normal during 48 weeks of treatment, and when you should contact your healthcare provider.
Jublia (efinaconazole 10% topical solution) is generally well tolerated, especially compared to oral antifungal medications. Since it is applied directly to the toenail with minimal absorption into the bloodstream, most side effects are localized to the application site. That said, it's important to know what to expect — and when to stop using it and call your doctor.
How Safe Is Jublia?
Jublia has a favorable safety profile. Because it is a topical medication applied to the nail surface, systemic absorption is very low — plasma concentrations are minimal even after daily application for 48 weeks. This means the risk of systemic side effects (those affecting the whole body) is much lower than with oral antifungal drugs.
Jublia also has no known significant drug interactions — a major advantage over oral terbinafine and itraconazole, which interact with multiple common medications.
Common Side Effects of Jublia (Occur in More Than 1% of Patients)
In clinical trials, the most common adverse reactions — occurring in more than 1% of patients — were related to the application site:
Ingrown toenail (2.3%): The most commonly reported side effect. Daily application around and under the nail can sometimes contribute to ingrown nails.
Application site dermatitis (2.2%): Redness and skin irritation at or around the treated nail.
Application site vesicles (1.6%): Small fluid-filled blisters at the application site.
Application site pain (1.1%): Pain, burning, or stinging when applying the solution.
Other reported reactions that may occur include itching, swelling, and redness around the treated toenail. These effects are typically mild and often improve as your body adjusts to the medication.
Serious Side Effects: When to Stop Jublia and Seek Medical Attention
Serious side effects with Jublia are rare but possible. Stop using Jublia and contact your doctor or seek emergency care if you experience:
Signs of a severe allergic reaction: Hives, significant swelling (especially of the face, lips, tongue, or throat), difficulty breathing, or feeling faint. This is a medical emergency — call 911.
Severe skin irritation: Intense redness, significant blistering, swelling, or open sores at the application site that don't improve with time. This may indicate significant contact dermatitis requiring medical evaluation.
Signs of a worsening or spreading infection: Increasing warmth, swelling, pus, or red streaks around the toenail — these can indicate a bacterial superinfection.
Special Warnings for Jublia
Flammability: Jublia's solution contains alcohol and is flammable. Keep it away from heat sources, open flames, and do not smoke while applying it. Allow it to dry completely before covering the treated area.
Pregnancy: There are no adequate well-controlled studies in pregnant women. Jublia should be used during pregnancy only if the potential benefit justifies the risk. Inform your provider if you are pregnant or planning to become pregnant.
Breastfeeding: It is unknown whether efinaconazole is excreted in human breast milk. Use caution and discuss with your provider before using Jublia while breastfeeding.
Tips for Minimizing Side Effects
Wait at least 10 minutes after showering or washing before applying Jublia to ensure nails are clean and dry
Allow the solution to dry completely before putting on socks or covering the foot
Avoid nail polish, gel nails, acrylic nails, or pedicures during treatment
Keep toenails trimmed short to reduce the risk of ingrown nails
Apply gently using the brush — do not press hard or squeeze the bottle while spreading
When Should I Expect to See Results?
Jublia works slowly — it treats the fungus at the nail's infection site, but results are only visible as the nail grows out and is replaced by healthy nail tissue. Toenails grow approximately 1 mm per month, and a full toenail replacement takes 12–18 months. Most patients don't see significant improvement until several months into treatment.
In clinical trials, complete cure was assessed at 52 weeks (4 weeks after completing the 48-week course). Don't be discouraged if the nail looks the same after the first 1–2 months — this is expected. Continue using Jublia as prescribed unless directed otherwise by your provider.
Need Help Filling Your Jublia Prescription?
medfinder can help locate pharmacies near you that have Jublia in stock. Also see our guide on Jublia drug interactions to understand any medications that could be a concern.
Frequently Asked Questions
The most common side effects of Jublia (efinaconazole), occurring in more than 1% of patients in clinical trials, are: ingrown toenail (2.3%), application site dermatitis/redness (2.2%), application site vesicles/blisters (1.6%), and application site pain (1.1%). Side effects are generally mild and localized to the treated area.
Jublia is prescribed for 48 weeks (almost a year) and has been studied in long-term clinical trials with an acceptable safety profile. Because systemic absorption is minimal, long-term organ toxicity (like liver damage seen with some oral antifungals) is not a concern with topical efinaconazole.
Yes, though rare. Signs of a serious allergic reaction include hives, facial swelling, difficulty breathing, or throat tightening. Stop using Jublia immediately and seek emergency medical care if you experience these symptoms. If you have a known allergy to other azole antifungals (such as clotrimazole, fluconazole, or ketoconazole), inform your doctor before using Jublia.
Some skin irritation at the application site is common, occurring in about 2.2% of patients in clinical trials. This typically presents as redness, mild inflammation, or a slight burning sensation. These effects are usually mild. If irritation is significant or doesn't improve, contact your prescriber — they may adjust your application technique or consider an alternative treatment.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Jublia also looked for:
More about Jublia
31,889 have already found their meds with Medfinder.
Start your search today.





